121 related articles for article (PubMed ID: 8960463)
41. Carboxyterminal propeptide of type I procollagen in osteomalacia.
Li F; Iqbal J; Wassif W; Kaddam I; Moniz C
Calcif Tissue Int; 1994 Aug; 55(2):90-3. PubMed ID: 7953986
[TBL] [Abstract][Full Text] [Related]
42. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
43. Course of three biochemical bone markers after kidney transplantation.
Gonzalez MT; Bonnin R; Cruzado JM; Garcia R; Moreso F; Fulladosa X; Alsina J; Navarro MA; Griñó JM
Transplant Proc; 1995 Aug; 27(4):2266-71. PubMed ID: 7652802
[No Abstract] [Full Text] [Related]
44. Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta.
Minisola S; Piccioni AL; Rosso R; Romagnoli E; Pacitti MT; Scarnecchia L; Mazzuoli G
Metabolism; 1994 Oct; 43(10):1261-5. PubMed ID: 7934978
[TBL] [Abstract][Full Text] [Related]
45. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
[TBL] [Abstract][Full Text] [Related]
46. Serum markers of bone metabolism in dogs.
Allen MJ; Hoffmann WE; Richardson DC; Breur GJ
Am J Vet Res; 1998 Mar; 59(3):250-4. PubMed ID: 9522938
[TBL] [Abstract][Full Text] [Related]
47. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.
Osella G; Terzolo M; Reimondo G; Piovesan A; Pia A; Termine A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1997 Oct; 82(10):3303-7. PubMed ID: 9329358
[TBL] [Abstract][Full Text] [Related]
48. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
[TBL] [Abstract][Full Text] [Related]
49. Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man.
Bianda T; Hussain MA; Glatz Y; Bouillon R; Froesch ER; Schmid C
J Intern Med; 1997 Feb; 241(2):143-50. PubMed ID: 9077371
[TBL] [Abstract][Full Text] [Related]
50. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
51. Significance of bone formation markers in patients with ossification of the posterior longitudinal ligament of the spine.
Sugimori K; Kawaguchi Y; Ohmori K; Kanamori M; Ishihara H; Kimura T
Spine (Phila Pa 1976); 2003 Feb; 28(4):378-9. PubMed ID: 12590214
[TBL] [Abstract][Full Text] [Related]
52. Do serological tissue turnover markers represent callus formation during fracture healing?
Seebeck P; Bail HJ; Exner C; Schell H; Michel R; Amthauer H; Bragulla H; Duda GN
Bone; 2005 Nov; 37(5):669-77. PubMed ID: 16126014
[TBL] [Abstract][Full Text] [Related]
53. [Importance of biochemical indicators of bone turnover in patients on chronic dialysis and after kidney transplantation].
Kusec V; Smalcelj R
Acta Med Croatica; 2004; 58(1):51-7. PubMed ID: 15125394
[TBL] [Abstract][Full Text] [Related]
54. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.
Kröger H; Risteli J; Risteli L; Penttilä I; Alhava E
Ann Rheum Dis; 1993 May; 52(5):338-42. PubMed ID: 8323381
[TBL] [Abstract][Full Text] [Related]
55. Characteristics of biochemical markers in patients with metabolic bone disorders.
Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
[TBL] [Abstract][Full Text] [Related]
56. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.
Linkhart SG; Linkhart TA; Taylor AK; Wergedal JE; Bettica P; Baylink DJ
Clin Chem; 1993 Nov; 39(11 Pt 1):2254-8. PubMed ID: 8222218
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
58. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
59. [Procollagen type I C-propeptide in kidney transplant recipients].
Vaccaro F; Gioviale MC; Picone FP; Buscemi G; Romano M
Minerva Med; 1996 Jun; 87(6):269-73. PubMed ID: 8700355
[TBL] [Abstract][Full Text] [Related]
60. Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases.
Ebeling PR; Peterson JM; Riggs BL
J Bone Miner Res; 1992 Nov; 7(11):1243-50. PubMed ID: 1466250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
